Third-party pharma manufacturing may rise amid US tariff uncertainty

AuthorPosted bypeoplic.com
PublishedSeptember 28, 20259:57 am

X (Twitter)
Facebook
LinkedIn
Share this post

Share this postClose sharing box
Third-party pharma manufacturing may rise amid US tariff uncertainty
X (Twitter)
Facebook
LinkedIn

Posted by peoplic.com on September 28, 2025.

Analysts say Indian drugmakers may lean on CDMOs, US plants and diversification to safeguard high-value products as Trump’s 100% tariff threat looms over patented drugs

Post Views: 1

M.G. Road to Bellandur in five to eight minutes? Defence Ministry agrees to handover land for road widening

Special committee to be formed to investigate Naveen Babu’s deteriorating health after June 10, says PM Modi

Welp, another JRPG is coming to devour my whole entire life as Trails in the Sky remake dev says you’ll need about 80 hours to beat the game – twice as much as the original game

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

0 Comments

Previous PostAll about Iran’s nuclear programme as UN reimposes ‘snapback’ sanctions

Next PostWith Scant Information, Federal Workers Brace for Possible Shutdown

Related Stories

M.G. Road to Bellandur in five to eight minutes? Defence Ministry agrees to handover land for road widening

Special committee to be formed to investigate Naveen Babu’s deteriorating health after June 10, says PM Modi

Welp, another JRPG is coming to devour my whole entire life as Trails in the Sky remake dev says you’ll need about 80 hours to beat the game – twice as much as the original game

Leave a Reply Cancel reply